跳至主要内容
临床试验/EUCTR2008-001447-19-NL
EUCTR2008-001447-19-NL进行中(未招募)1 期

Prophylactic infusion of CD4 positive donor lymphocytes early after T-cell depleted stem cell transplantation

eiden University Medical Center0 个研究点目标入组 60 人开始时间: 2008年5月29日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with AML, myelodysplasia (MDS), ALL, CML in accelerated phase or blastic transformation, CLL, MM or aggressive lymphoma, who are scheduled to receive an allogeneic transplantation.
  • Absence of any concomitant disease preventing the safe administration of donor lymphocytes
  • WHO performance status of 0, 1 or 2 (see appendix)
  • No pregnancy, not breast feeding
  • Life expectation of > 3 months
  • No severe psychological disturbances
  • No HIV positivity (tested at time of alloSCT)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Systemic immunosuppressive treatment
  • Progressive GVHD
  • GVHD of the skin > grade 2 (see appendix)
  • Progressive disease needing cytoreductive treatment

研究者

发起方
eiden University Medical Center

相似试验